Great results!
just their outlook statement about COVId slowing closing deals therefore FY21 NPAT could be flat vs FY20, appears a bit clumsy IMHO. Their webcast explanations to analysts didn't shed any further light, they just came across as unsure, therefore why be so pessimistic.
If it dips significantly on this today, would be a good buying opportunity.
- Forums
- ASX - By Stock
- BVS
- Ann: FY20 Results Announcement
BVS
bravura solutions limited.
Add to My Watchlist
0.90%
!
$2.24

Ann: FY20 Results Announcement, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
0.020(0.90%) |
Mkt cap ! $1.004B |
Open | High | Low | Value | Volume |
$2.21 | $2.30 | $2.20 | $1.937M | 859.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16253 | $2.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.26 | 6753 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3652 | 2.190 |
3 | 30000 | 2.180 |
2 | 18216 | 2.170 |
1 | 450 | 2.150 |
1 | 7000 | 2.140 |
Price($) | Vol. | No. |
---|---|---|
2.260 | 500 | 1 |
2.300 | 815 | 1 |
2.310 | 236 | 1 |
2.320 | 740 | 1 |
2.400 | 1580 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online